Hydrocolloids Market Size Worth $13.61 Billion By 2025

The global hydrocolloids market size is expected to reach USD 13.61 billion by 2025, as per a new report by Grand View Research Inc. It is anticipated to expand at a CAGR of 6.5% during the forecast period. Hydrocolloids find application in radiology as a suspending agent, suppositories, slow release capsules, emulsions, surgical lubricants, and as a carrier of topical medicaments, which is expected to drive the market growth.

Rapid urbanization coupled with improved consumer lifestyle with more emphasis on healthy, diet-friendly, nutritious, and natural products is fueling the demand for convenience and packaged foods, which, in turn, is likely to propel the product consumption. Additionally, growing consumer awareness regarding the benefits of nutritional food is further propelling the demand for hydrocolloids in developing countries, such as China and India.

Europe and North America are projected to play a substantial role even after losing their market share to Asia Pacific and Latin America. Asia Pacific and Latin America are expected to accomplish the highest gains in near future. A large number of health-conscious individuals are embracing a healthier lifestyle with the foremost importance on the healthy food choices offered by various food and beverage companies.

The key players in the hydrocolloids market are inclined towards new product launches, which is expected to augment the growth. In August 2018, Cargill announced its plans to invest USD 150 million in Brazil production facility to keep up with the increasing demand for pectin.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/hydrocolloids-market

  • Growing demand for processed food due to the convenience is expected to positively impact hydrocolloid market in the forthcoming years
  • Processed foods market has seen healthy growth in recent past and is projected to witness high growth in near future
  • The ability of hydrocolloids to reduce the fat content by dispersing water and acting as a fat replacer in food products is expected to propel their demand as consumers are increasingly preferring low-fat and low-calorie food products
  • The shortage of resources and vulnerability to seasonal changes cause volatility in the raw material pricing is propelling manufacturing costs and limiting the market growth
  • Rise in population coupled with rising disposable income, translates into an enhanced standard of living, particularly in the developing regions. This is anticipated to result in a steady growth in demand for specialty and processed food products

Excipients Market Size Worth $6.9 Billion By 2025

The global excipients market size is expected to reach USD 6.9 billion by 2025, expanding at a CAGR of 6.02% from 2017 to 2025, according to a new report by Grand View Research, Inc. Globally increasing reach of generic medicines has been a major factor driving market growth. In addition, rising demand for newer excipients owing to the advantages of drug delivery and stability has led to the growth of the market. 

Excipients are essential components for the improvement of overall pharmaceutical activity and performance, both of which directly impact the characteristics of pharmaceutical formulations. An excipient in the right proportion can improve the shelf life and bioavailability of a formulation. These can also be used in drug delivery mechanisms such as sustained release and rapid release drugs.

Polymers were the largest product category in 2016 and are expected to maintain a comparatively moderate growth rate over the forecast period. Microcrystalline cellulose was the leading polymer in this category, accounting for a share of over 26.0% in 2016.

Sugars are expected to observe the fastest growth over the  coming years, exhibiting an estimated CAGR of 5.1% from 2017 to 2025. Sugars can play an instrumental role in increasing solubility, taste masking, dissolution, and drug delivery, which can drive its market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/excipients-market-analysis

Further key findings from the report suggest:

  • The global excipients demand exceeded 600,000 tons in 2016 and is expected to grow at a moderate rate from 2017 to 2025
  • Owing to high market demand, polymer excipients accounted for the largest revenue share in 2016 and the segment can be anticipated to dominate the market for the coming years as well
  • The global demand for sugars excipients was valued at over USD 1 billion in 2016 and is anticipated to witness significant growth over the coming years
  • The Europe polymers market was pegged at 74,000 tons in 2015 and is estimated to reach a total volume of over 100,000 tons by 2025
  • The market in Asia Pacific is projected to witness substantial growth over the course of the forecast period thanks to several development projects undertaken across major economies, especially in newer excipients markets. The regional market is expected to register a CAGR of 6.63% from 2017 to 2025
  • Key market participants include Eastman Chemical Corporation; P&G Chemicals; Avantor Performance Materials, LLC; Huntsman Corporation; BASF SE; Ashland Inc.; FMC Corporation; Roquette; Colorcon Inc.; Lubrizol Corporation; Valeant; JRS Pharma; Shin-Etsu Chemical Co., Ltd.; DFE Pharma; and Finar Limited.

Collagen Market Size Worth $7.5 Billion By 2027

The global collagen market size is expected to reach USD 7.5 billion by 2027, expanding at a revenue-based CAGR of 6.4%, according to a new report by Grand View Research, Inc. The growth in the market can be attributed to high demand for collagen in cosmetic surgeries and wound healing treatments. Increasing consumer spending capacities coupled with the popularity of skin surgeries has propelled product demand across the world.

Bovine, porcine, poultry, and marine are the four main sources required for manufacturing collagen. Collagen from bovine source accounts for a substantial share of 35% as of 2019, as opposed to other sources, on account of the abundance of bovine sources and relatively lower price as compared to marine and porcine sources. Marine is superior to that of bovine or porcine sources, owing to its high absorption rate and bioavailability. However, the product obtained from marine costs relatively higher than from bovine and porcine, which is expected to restrain the growth of the segment.

The gelatin segment dominated the market in 2019 owing to the substantial demand for the product as a food stabilizer. The growth of fishing industry in India and China has attracted gelatin manufacturers in the Asia Pacific to use fish as a raw material for gelatin production. The market for hydrolyzed collagen is also anticipated to register the fastest growth over the forecast period, backed by its increasing use in the healthcare sector for tissue repair and dental applications. Increasing efforts by the companies for using hydrolyzed collagen in the treatment of bone related disorders, such as osteoarthritis have favored the growth of the segment.

The key applications for the product include food and beverages, healthcare, and cosmetics. Healthcare emerged as the largest application segment of the industry in 2019 and is forecasted to retain its dominant position over the forecast period. The food and beverage industry is expected to be a major contributor to the demand for gelatin and hydrolyzed collagen, as the product is an essential protein for the human body and has multiple nutritional, skin, and health benefits.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/collagen-market

Further key findings from the report suggest:

  • The collagen market size is anticipated to reach USD 7.5 billion by 2027, at a revenue-based CAGR of 6.4% from 2020 to 2027
  • In terms of revenue, the marine source segment is projected to ascend at a CAGR of 7.3% over the forecast period
  • In terms of volume, cosmetic surgery and wound healing emerged as the largest healthcare application segment in 2019, owing to its ability to treat chronic wounds as they inhibit the action of metalloproteinase
  • Asia Pacific is projected to witness a remarkable growth rate of 6.6% in terms of volume, in the near future, owing to the increasing consumption of healthcare and cosmetic products in the region
  • Some of the key players operating in the industry include Koninklijke DSM N.V.; Collagen Matrix; CONNOILS LLC; Rousselot BV; and Advanced BioMatrix, Inc.